OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Nanoparticles and Vaccine Development
Mehdi Kheirollahpour, Mohsen Mehrabi, Naser Mohammadpour Dounighi, et al.
Pharmaceutical Nanotechnology (2019) Vol. 8, Iss. 1, pp. 6-21
Closed Access | Times Cited: 150

Showing 1-25 of 150 citing articles:

Application prospect of polysaccharides in the development of anti-novel coronavirus drugs and vaccines
Xiangyan Chen, Wenwei Han, Guixiang Wang, et al.
International Journal of Biological Macromolecules (2020) Vol. 164, pp. 331-343
Open Access | Times Cited: 145

Nanoparticle-Based Delivery Systems for Vaccines
Rajashri Bezbaruah, Vivek P. Chavda, Lawandashisha Nongrang, et al.
Vaccines (2022) Vol. 10, Iss. 11, pp. 1946-1946
Open Access | Times Cited: 131

Liposome-based delivery of biological drugs
Kosheli Thapa Magar, George Frimpong Boafo, Xiaotong Li, et al.
Chinese Chemical Letters (2021) Vol. 33, Iss. 2, pp. 587-596
Closed Access | Times Cited: 123

Nanobiotics against antimicrobial resistance: harnessing the power of nanoscale materials and technologies
Nayanika Chakraborty, Diksha Jha, Indrajit Roy, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 95

Nanoparticles in Clinical Trials: Analysis of Clinical Trials, FDA Approvals and Use for COVID-19 Vaccines
Eugenia D. Namiot, Aleksandr V. Sokolov, Vladimir N. Chubarev, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 1, pp. 787-787
Open Access | Times Cited: 82

Nanovaccines: A game changing approach in the fight against infectious diseases
Priyanka Choudhary, Mai Abdel Haleem Abusalah, Hitesh Chopra, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 167, pp. 115597-115597
Open Access | Times Cited: 72

An Overview of Nanocarrier-Based Adjuvants for Vaccine Delivery
Kailash C. Petkar, Suyash M. Patil, Sandip S. Chavhan, et al.
Pharmaceutics (2021) Vol. 13, Iss. 4, pp. 455-455
Open Access | Times Cited: 81

Nanotechnology-empowered vaccine delivery for enhancing CD8+ T cells-mediated cellular immunity
Liu Guang-na, Motao Zhu, Xiao Zhao, et al.
Advanced Drug Delivery Reviews (2021) Vol. 176, pp. 113889-113889
Closed Access | Times Cited: 78

A Systematic Review on COVID-19 Vaccine Strategies, Their Effectiveness, and Issues
Shahad Saif Khandker, Brian Godman, Md. Irfan Jawad, et al.
Vaccines (2021) Vol. 9, Iss. 12, pp. 1387-1387
Open Access | Times Cited: 73

Nano toolbox in immune modulation and nanovaccines
Mohammad Azharuddin, Geyunjian Harry Zhu, Anirban Sengupta, et al.
Trends in biotechnology (2022) Vol. 40, Iss. 10, pp. 1195-1212
Open Access | Times Cited: 62

Use of Protamine in Nanopharmaceuticals—A Review
Ivana Ruseska, Katja Fresacher, Christina Petschacher, et al.
Nanomaterials (2021) Vol. 11, Iss. 6, pp. 1508-1508
Open Access | Times Cited: 60

Modern biotechnological strategies for vaccine development in aquaculture – Prospects and challenges
T.A. Jose Priya, Sudha Kappalli
Vaccine (2022) Vol. 40, Iss. 41, pp. 5873-5881
Closed Access | Times Cited: 43

Tilapia Lake Virus Vaccine Development: A Review on the Recent Advances
Japhette E. Kembou-Ringert, Dieter Steinhagen, John Readman, et al.
Vaccines (2023) Vol. 11, Iss. 2, pp. 251-251
Open Access | Times Cited: 27

Nanotechnology in the Diagnosis and Treatment of Antibiotic-Resistant Infections
Πέτρος Ιωάννου, Stella Baliou, George Samonis
Antibiotics (2024) Vol. 13, Iss. 2, pp. 121-121
Open Access | Times Cited: 14

Polymer Nanoparticles for Cancer Immunotherapy: Preparation Methods and Applications
Ashish Kumar Parashar, Vandana Arora Sethi
Nature Cell and Science (2024) Vol. 000, Iss. 000, pp. 000-000
Open Access | Times Cited: 10

Vaccines and Monoclonal Antibodies as Alternative Strategies to Antibiotics to Fight Antimicrobial Resistance
Chiara La Guidara, Roberto Adamo, Claudia Sala, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 10, pp. 5487-5487
Open Access | Times Cited: 9

Application of biomimetic nanovaccines in cancer immunotherapy: A useful strategy to help combat immunotherapy resistance
Zhijie Xu, Zhou Hai-yan, Tongfei Li, et al.
Drug Resistance Updates (2024) Vol. 75, pp. 101098-101098
Closed Access | Times Cited: 9

Design of periodontitis vaccine: Target, adjuvant, and delivery system
Cancan Huang, Rushui Bai, Ting Zhang, et al.
Deleted Journal (2025) Vol. 2, Iss. 1, pp. 100052-100052
Closed Access | Times Cited: 1

Current view on novel vaccine technologies to combat human infectious diseases
Zrinka Matić, Maja Šantak
Applied Microbiology and Biotechnology (2021) Vol. 106, Iss. 1, pp. 25-56
Open Access | Times Cited: 55

Current Advances in Lipid and Polymeric Antimicrobial Peptide Delivery Systems and Coatings for the Prevention and Treatment of Bacterial Infections
Miriam E. van Gent, Muhanad Ali, Peter H. Nibbering, et al.
Pharmaceutics (2021) Vol. 13, Iss. 11, pp. 1840-1840
Open Access | Times Cited: 53

Recent Advances and Future Perspectives in Polymer-Based Nanovaccines
Νatassa Pippa, Maria Gazouli, Stergios Pispas
Vaccines (2021) Vol. 9, Iss. 6, pp. 558-558
Open Access | Times Cited: 45

Peptide-Based Nanovaccines in the Treatment of Cervical Cancer: A Review of Recent Advances
Jiahui Zhang, Jingyi Fan, Mariusz Skwarczyński, et al.
International Journal of Nanomedicine (2022) Vol. Volume 17, pp. 869-900
Open Access | Times Cited: 36

The use of nanotechnology in the fight against viruses: A critical review
Elaheh K. Goharshadi, Kimiya Goharshadi, Marjan Moghayedi
Coordination Chemistry Reviews (2022) Vol. 464, pp. 214559-214559
Closed Access | Times Cited: 35

Current progress in the development of prophylactic and therapeutic vaccines
Tingting Li, Ciying Qian, Ying Gu, et al.
Science China Life Sciences (2022) Vol. 66, Iss. 4, pp. 679-710
Open Access | Times Cited: 31

Vaccine development for bacterial pathogens: Advances, challenges and prospects
Ifeanyi Elibe, Hyelnaya Cletus Sharndama, Zikora Kizito Glory Anyaegbunam, et al.
Tropical Medicine & International Health (2023) Vol. 28, Iss. 4, pp. 275-299
Open Access | Times Cited: 21

Page 1 - Next Page

Scroll to top